Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
43.60
+0.08 (0.18%)
Dec 10, 2025, 1:26 PM EST - Market open
Xenon Pharmaceuticals Employees
As of December 31, 2024, Xenon Pharmaceuticals had 327 total employees, including 316 full-time and 11 part-time employees. The number of employees increased by 68 or 26.25% compared to the previous year.
Employees
327
Change (1Y)
68
Growth (1Y)
26.25%
Revenue / Employee
$22,936
Profits / Employee
-$936,801
Market Cap
3.37B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
XENE News
- 5 days ago - Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025 - GlobeNewsWire
- 5 days ago - Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 days ago - Xenon Announces Investor Webinar Highlighting Azetukalner and Epilepsy Data from AES 2025 - GlobeNewsWire
- 15 days ago - Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025 - GlobeNewsWire
- 4 weeks ago - Xenon to Present at Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Xenon Pharmaceuticals Inc. (XENE) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Xenon Reports Third Quarter 2025 Financial Results & Business Update - GlobeNewsWire
- 6 weeks ago - Xenon to Report Q3 2025 Financial Results on November 3, 2025 - GlobeNewsWire